Precision AQ
The Research Analyst will support the development and commercialization of oncology portfolios by integrating therapeutic, clinical, and commercial expertise to inform client decision-making. The role contributes to evidence generation and insight development for product launch and lifecycle activities across global clients. It is positioned within a growing organization where analytical rigor and clear communication of findings drive commercial and clinical strategy.
Precision AQ is a healthcare access and commercialization firm focused on empowering access to life‑changing medicines. With a team of more than 1,200 experts, it partners with biopharma and healthcare organizations to design and implement strategies that improve patient access, reimbursement, and product commercialization. The company combines commercial expertise, operational services, and technology-enabled solutions to streamline access pathways and drive adoption. Clients rely on Precision AQ for end-to-end programs that optimize launches and expand patient reach.
Precision AQ expands senior leadership team to strengthen global AI, data strategy, evidence synthesis and economic modelling capabilities
3 weeks ago
40 Under 40: Hannah Deresiewicz, Precision AQ
1 month ago
Precision AQ Invests in Phluence to Advance Next Generation of Agentic Patient Solutions
Nov 18, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Precision AQ.
Precision AQ didn’t post a salary, so this is our estimate from similar listings.
Agency 100 2025: Precision AQ - MM+M
Jun 10, 2025